SCHEMBL4693339

SCHEMBL4693339

Oc1ccc(C2=NCCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 12/20 0.55
CHRNA3 P32297 12/20 0.55
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
THRB P10828 1/20 0.48
CYP2C19 P33261 1/20 0.48
CHRNA7 P36544 2/20 0.42
ESR1 P03372 2/20 0.42
ESR2 Q92731 1/20 0.42
MAOB P27338 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24414772 0.78 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL3574404 0.78 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL15665457 0.78 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL2045328 0.78 CHRNB4 (0.57) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL14047263 0.78 CHRNB4 (0.54) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL165812 0.77 CHRNB4 (0.87) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL4090821 0.76 CHRNB4 (0.53) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL31271501 0.74 ESR1 (0.53) ALDH1A1ESR1ESR2MAOBMEN1
SCHEMBL23892004 0.74 CHRNB4 (0.50) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL20411025 0.74 CHRNB4 (0.60) CHRNB4CHRNA3ALDH1A1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1419160-B1 METHOD FOR THE PRODUCTION OF 6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YLACETIC ACID MERCKLE GMBH (DE) 2008-12-10 EP disclosed
US-7078535-B2 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2006-07-18 US disclosed
US-20040236117-A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid MERCKLE GMBH (DE) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040236117-A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid KMO, HPD, PDK4 CHRNB4 1937/4885CHRNA3 2603/4885ALDH1A1 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.